| Literature DB >> 22953994 |
Erwin C P M Tak1, Ariëtte van Hespen, Paula van Dommelen, Marijke Hopman-Rock.
Abstract
BACKGROUND: Urinary incontinence (UI) is a major problem in older women. Management is usually restricted to dealing with the consequences instead of treating underlying causes such as bladder dysfunction or reduced mobility.The aim of this multicenter randomized controlled trial was to compare a group-based behavioral exercise program to prevent or reduce UI, with usual care. The exercise program aimed to improve functional performance of pelvic floor muscle (PFM), bladder and physical performance of women living in homes for the elderly.Entities:
Mesh:
Year: 2012 PMID: 22953994 PMCID: PMC3495708 DOI: 10.1186/1471-2318-12-51
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Baseline characteristics of intervention group and control group
| Age, years (SD) | 84.6 (6.5) | 84.7 (5.7) |
| Education(N) | | |
| High (%) | 14 | 6 |
| Intermediate (%) | 19 | 20 |
| Low (%) | 52 | 44 |
| Cognition, 0-14‡ (SD) | 12.7 (2.0) | 12.7 (1.4) |
| Barthel index, 0-20† (SD) | 16.1 (3.6) | 15.4 (2.8) |
| Length of Stay, months (SD) | 61.6 (65.5) | 42.1 (43.6) |
| Subjective urinary incontinence (# participants) | 46 | 39 |
| Subjective fecal incontinence (# participants) | 31 | 20 |
| Comorbidity, number of chronic illnesses (SD) | 1.8 (1.9) | 3.0 (2.3)*** |
| Number of incontinence pads in 3 weeks (SD) | 63.7 (43.6) | 54.4 (31.2) |
*** p < .001; ‡ higher score indicates better performance; † higher sco1re indicates worse performance.
Regression analysis for intervention (n = 85) and control (n = 70) group
| Number of participants with UI | ||||
| Intervention group | 40 | 37 | 40 | 0.66 (0.15,2.90), 0.80 (0.34,1.88) |
| Control group | 40 | 38 | 34 | |
| Frequency incontinence episodes (Number/ 3 days); mean (sd) | ||||
| Intervention group | 8.0 (11.0) | 6.6 (9.1) | 9.0 (11.4) | −1.71 (−5.99,2.56), 1.38 (−3.03,5.79) |
| Control group | 9.5 (11.5) | 7.4 (10.1) | 7.1 (9.6) | |
| Physical Performance Test (0-28†); mean (sd) | ||||
| Intervention group | 17.2 (4.87) | | 18.5 (4 14) | 3.21 (1.81,4.62), p < 0.001 |
| Control group | 15.8 (5.16) | | 14.7 (4.27) | |
| Health Related Quality of Life SF-12 (mental; 0-100); mean (sd) | ||||
| Intervention group | 47.0 (14.2) | | 52.0 (10.0) | 0.07 (−4.24,4.39) |
| Control group | 46.0 (12.8) | | 51.3 (8.5) | |
| Health Related Quality of Life SF-12 (physical; 0-100†); mean (sd) | ||||
| Intervention group | 34.7 (12.0) | | 38.3 (11.6) | 1.70 (−3.39,6.80) |
| Control group | 34.1 (10.1) | | 35.0 (12.1) | |
| Specific Quality of Life (I-QOL; 0-110†); mean (sd) | ||||
| Intervention group | 68.9 (17.9) | | 65.7 (15.6) | −3.30 (−10.2,3.63) |
| Control group | 62.2 (17.7) | 66.2 (15.6) | ||
*corrected for chronic status.
† Higher score indicates better performance.
Figure 1Study flowchart.
Results Per Protocol Analysis
| Number of participants with UI | ||||
| Intervention group | 29/51 | 25/51 | 18/51 | Z = −.053‡ |
| Control group | 36/60 | 31/60 | 26/60 | Z = −.531§ |
| Frequency incontinence episodes (Number/ 3 days); mean (sd) | ||||
| Intervention group (n = 51) | 9.0 (12.2) | 6.6 (9.6) | 4.4 (7.4) | F = 0.1 |
| Control group (n = 60) | 9.3 (11.3) | 7.1 (10.5) | 5.4 (8.5) | |
| Physical Performance Test (0-28†); mean (sd) | ||||
| Intervention group (n = 51) | 16.7 (4.7) | - | 18.8 (3.9) | F = 10.1* |
| Control group (n = 60) | 16.4 (4.5) | - | 15.7 (4.5) | |
| Health Related Quality of Life SF-12 (mental; 0-100†); mean (sd) | ||||
| Intervention group (n = 51) | 51.4 (10.5) | - | 49.9 (10.9) | F = 1.5 |
| Control group (n = 60) | 52.7 (10.1) | - | 53.6 (7.7) | |
| Health Related Quality of Life SF-12 (physical; 0-100†); mean (sd) | ||||
| Intervention group (n = 51) | 35.5 (11.0) | - | 36.6 (11.2) | F = 2.4 |
| Control group (n = 60) | 34.7 (10.2) | - | 32.4 (11.2) | |
| Specific Quality of Life (I-QOL; 0-110†); mean (sd) | ||||
| Intervention group (n = 51) | 66.6 (15.0) | - | 63.5 (15.0) | F = 0.5∥ |
| Control group (n = 60) | 59.1 (15.2) | - | 66.1 (13.2) | |
* p < .01.
† Higher score indicates better performance.
‡ difference between baseline and 3 months (Mann–Whitney Test).
§ difference between baseline and 6 months (Mann–Whitney Test).
∥Corrected for baseline difference.